UK Markets closed

GW Pharmaceuticals plc (GWPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
214.95+0.01 (+0.00%)
As of 3:10PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close214.94
Open214.75
Bid215.04 x 800
Ask215.08 x 1000
Day's range214.63 - 215.13
52-week range67.98 - 217.50
Volume993,826
Avg. volume935,075
Market cap6.64B
Beta (5Y monthly)2.00
PE ratio (TTM)N/A
EPS (TTM)-1.86
Earnings date10 May 2021 - 14 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est204.90
  • Why GW Pharmaceuticals Stock Rocketed 40.5% in February
    Motley Fool

    Why GW Pharmaceuticals Stock Rocketed 40.5% in February

    Shares of GW Pharmaceuticals (NASDAQ: GWPH) rose 40.5% in February, according to data provided by S&P Global Market Intelligence. The bulk of the move came on Feb. 3 when Jazz Pharmaceuticals (NASDAQ: JAZZ) announced it would be purchasing GW for $7.2 billion, or the equivalent of $220 per share, made up of $200 per share in cash and $20 in Jazz stock. GW has the only drug made from cannabis, the emerging blockbuster Epidiolex.

  • Investors: The Marijuana Boom Is Now
    Zacks

    Investors: The Marijuana Boom Is Now

    Marijuana will provide the basis for many of tomorrow's blockbuster drugs. David Borun shows you how to invest in this burgeoning industry.

  • The 10 Best Marijuana Stocks in February
    Motley Fool

    The 10 Best Marijuana Stocks in February

    Following a more than one-year downtrend, there's no longer any doubt about it: Marijuana stocks are back in a big way. The excitement surrounding pot stocks was readily evident when analyzing their monthly returns in February. Whereas the benchmark S&P 500 ended last month higher by 2.6%, 10 marijuana stocks crossed the finish line with a gain of at least 20%.